Herbalife, Allergan Lead To Questions Over Ackman Strategy

Bill Ackman’s career as an activist investor has been distinguished by impressive wins and huge losses, but the number of bets falling into the latter category has been on the rise as he has shown a bias for more aggressive plays that some experts say set management on the defensive and cast a pall over all activist investors.